Conformational Effects of Environmentally Induced, Cancer-related Mutations in the P53 Protein

Overview

Journal Proc Natl Acad Sci U S A

Specialty Science

Date 1994 Sep 27

PMID 7937752

Citations 3

Authors

P W Brandt-Rauf

R Monaco

M R Pincus

Affiliations

Soon will be listed here.

Abstract

The tumor suppressor gene p53 has been identified as the most frequent target of genetic alterations in human cancers. A considerable number of environmentally induced, cancer-related p53 mutations in human tumors have been found in a highly conserved proline-rich sequence of the p53 protein encompassed by amino acid residues 147-158. Using conformational energy analysis based on ECEPP (Empirical Conformational Energy for Peptides Program), we have determined the low-energy three-dimensional structures for this dodecapeptide sequence for the human wild-type p53 protein and three environmentally induced, cancer-related mutant p53 proteins with His-151, Ser-152, and Val-154, respectively. The results suggest that the wild-type sequence adopts a well-defined low-energy conformation and that the mutant peptides adopt well-defined conformations that are distinctly different from the conformation of the wild-type peptide. These results are consistent with experimental conformational studies demonstrating altered detectability of antigenic epitopes in wild-type and mutant p53 proteins. These results suggest that the oncogenic effects of these environmentally induced, cancer-related, mutant p53 proteins may be mediated by distinct local conformational changes in the protein.

Citing Articles

Roles of computational modelling in understanding p53 structure, biology, and its therapeutic targeting.

Sing Tan Y, Mhoumadi Y, Verma C J Mol Cell Biol. 2019; 11(4):306-316.

PMID: 30726928 PMC: 6487789. DOI: 10.1093/jmcb/mjz009.

Large-Scale Analysis of Breast Cancer-Related Conformational Changes in Proteins Using Limited Proteolysis.

Liu F, Fitzgerald M J Proteome Res. 2016; 15(12):4666-4674.

PMID: 27794609 PMC: 5270647. DOI: 10.1021/acs.jproteome.6b00755.

Conformational effects in the p53 protein of mutations induced during chemical carcinogenesis: molecular dynamic and immunologic analyses.

Brandt-Rauf P, Chen J, Marion M, Smith S, Luo J, Carney W J Protein Chem. 1996; 15(4):367-75.

PMID: 8819013 DOI: 10.1007/BF01886863.

References

Brandt-Rauf P, Rackovsky S, Pincus M . Correlation of the structure of the transmembrane domain of the neu oncogene-encoded p185 protein with its function. Proc Natl Acad Sci U S A. 1990; 87(21):8660-4. PMC: 55017. DOI: 10.1073/pnas.87.21.8660. View

Stratton M, Moss S, Warren W, Patterson H, Clark J, Fisher C . Mutation of the p53 gene in human soft tissue sarcomas: association with abnormalities of the RB1 gene. Oncogene. 1990; 5(9):1297-301. View

Levine A, Momand J, Finlay C . The p53 tumour suppressor gene. Nature. 1991; 351(6326):453-6. DOI: 10.1038/351453a0. View

Hollstein M, Sidransky D, Vogelstein B, Harris C . p53 mutations in human cancers. Science. 1991; 253(5015):49-53. DOI: 10.1126/science.1905840. View

Brash D, Rudolph J, Simon J, Lin A, McKenna G, Baden H . A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma. Proc Natl Acad Sci U S A. 1991; 88(22):10124-8. PMC: 52880. DOI: 10.1073/pnas.88.22.10124. View

Brandt-Rauf P, Bomzer G, Belford D, Pincus M . An activating amino acid substitution in the c-abl oncogene protein fails to produce a local conformational change. J Protein Chem. 1991; 10(4):437-41. DOI: 10.1007/BF01025258. View

Vahakangas K, Samet J, Metcalf R, Welsh J, BENNETT W, Lane D . Mutations of p53 and ras genes in radon-associated lung cancer from uranium miners. Lancet. 1992; 339(8793):576-80. DOI: 10.1016/0140-6736(92)90866-2. View

Caron de Fromentel C, Soussi T . TP53 tumor suppressor gene: a model for investigating human mutagenesis. Genes Chromosomes Cancer. 1992; 4(1):1-15. DOI: 10.1002/gcc.2870040102. View

Konishi M, Ito S, Seki M, Tanaka K, Maeda Y, Iino H . Genetic changes of both p53 alleles associated with the conversion from colorectal adenoma to early carcinoma in familial adenomatous polyposis and non-familial adenomatous polyposis patients. Cancer Res. 1992; 52(14):3965-71. View

10.

Kress S, Sutter C, Strickland P, Mukhtar H, Schweizer J, Schwarz M . Carcinogen-specific mutational pattern in the p53 gene in ultraviolet B radiation-induced squamous cell carcinomas of mouse skin. Cancer Res. 1992; 52(22):6400-3. View

11.

Brandt-Rauf P, De Vivo I, Dykes D, Pincus M . Conformational effects of selected cancer-related amino acid substitutions in the p53 protein. J Biomol Struct Dyn. 1992; 10(2):253-64. DOI: 10.1080/07391102.1992.10508645. View

12.

Ponnuswamy P, Warme P, Scheraga H . Role of medium-range interactions in proteins. Proc Natl Acad Sci U S A. 1973; 70(3):830-3. PMC: 433369. DOI: 10.1073/pnas.70.3.830. View

13.

Tanaka S, Scheraga H . Theory of the cooperative transition between two ordered conformations of poly(L-proline). I. Phenomenological theory. Macromolecules. 1975; 8(4):494-503. DOI: 10.1021/ma60046a023. View

14.

Dygert M, Go N, Scheraga H . Use of a symmetry condition to compute the conformation of gramicidin S1. Macromolecules. 1975; 8(6):750-61. DOI: 10.1021/ma60048a016. View

15.

Zimmerman S, Pottle M, NEMETHY G, Scheraga H . Conformational analysis of the 20 naturally occurring amino acid residues using ECEPP. Macromolecules. 1977; 10(1):1-9. DOI: 10.1021/ma60055a001. View

16.

Pincus M, Klausner R, Scheraga H . Calculation of the three-dimensional structure of the membrane-bound portion of melittin from its amino acid sequence. Proc Natl Acad Sci U S A. 1982; 79(16):5107-10. PMC: 346840. DOI: 10.1073/pnas.79.16.5107. View

17.

Matlashewski G, Lamb P, Pim D, Peacock J, Crawford L, Benchimol S . Isolation and characterization of a human p53 cDNA clone: expression of the human p53 gene. EMBO J. 1984; 3(13):3257-62. PMC: 557846. DOI: 10.1002/j.1460-2075.1984.tb02287.x. View

18.

Pincus M, Brandt-Rauf P . Structural effects of substitutions on the p21 proteins. Proc Natl Acad Sci U S A. 1985; 82(11):3596-3600. PMC: 397832. DOI: 10.1073/pnas.82.11.3596. View

19.

Finlay C, Hinds P, Tan T, Eliyahu D, Oren M, Levine A . Activating mutations for transformation by p53 produce a gene product that forms an hsc70-p53 complex with an altered half-life. Mol Cell Biol. 1988; 8(2):531-9. PMC: 363177. DOI: 10.1128/mcb.8.2.531-539.1988. View

20.

Brandt-Rauf P, Carty R, Chen J, Avitable M, Lubowsky J, Pincus M . Structure of the carboxyl terminus of the RAS gene-encoded P21 proteins. Proc Natl Acad Sci U S A. 1988; 85(16):5869-73. PMC: 281866. DOI: 10.1073/pnas.85.16.5869. View